Ideas And Forecasts On Editas Medicine Inc (NASDAQ: EDIT)

Editas Medicine Inc (NASDAQ:EDIT) currently has a daily average trading volume of 3.99M but it saw 7760908 shares traded in last market. With a market cap of 151.06M USD, the company’s current market price of $1.83 came falling about -0.54 while comparing to the previous closing price of $1.84. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.58 and as low as $1.12.

Taking a look at 20-day trading activity of Editas Medicine Inc (EDIT) gives us an average price of $1.5900, while its current price level is -84.20% below from 52-week high level whereas it is 63.39% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.4246 while that of 200 days or SMA-200 reads an average of $3.3999. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.89% during that period while stretching the period over a month that decreases to 16.81%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 53.65 which implies that the stock is in neutral territory.

Stifel also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $11 and $3.

Over the week, EDIT’s stock price is moving -11.17% down while it is 28.87% when we observe its performance for the past one month. Year-to-date it is 44.09% up and over the past year, the stock is showing a downside performance of -77.30%.

Currently, Editas Medicine Inc’s total number of outstanding shares is 82.54M with 0.61% of that held by the insiders while 66.94% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -106.50% and return on equity (ROE) at -78.56%. Stock’s beta reads 1.88. Stock has a price to book (P/B) ratio of 0.86 while price to sale or P/S ratio amounts to 2.45. Its return on asset (ROA) is -50.61% on average.